Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Dec;62(6):1047–1051. doi: 10.1038/bjc.1990.437

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.

F Esteban 1, A Concha 1, M Delgado 1, M Pérez-Ayala 1, F Ruiz-Cabello 1, F Garrido 1
PMCID: PMC1971557  PMID: 2257212

Abstract

A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastases and normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal antibodies and the APAAP technique. We found 13 tumours presenting total HLA-ABC loss, five with selective loss of HLA-A antigens and one with absence of HLA-B antigens. These losses were statistically associated with clinical and pathological parameters, such as T stage, degree of differentiation, scores according to the Jakobsson and Glanz grading systems and degree of leukocytic infiltration. Our results lead us to the following conclusions: (a) HLA class I losses were found in a group of tumours showing greater aggressiveness and worse prognosis; (b) these alterations in expression were not associated with an increased metastatic potential. Thus, the absence of HLA molecules in laryngeal tumours is related to greater local aggressiveness, and the loss of class I antigens seems to constitute an adaptive tumour mechanism to avoid the different anatomical and immunological barriers within the larynx.

Full text

PDF
1047

Images in this article

1048Figure 1
on p.1048
1048Figure 2
on p.1048

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bröcker E. B., Suter L., Brüggen J., Ruiter D. J., Macher E., Sorg C. Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer. 1985 Jul 15;36(1):29–35. doi: 10.1002/ijc.2910360106. [DOI] [PubMed] [Google Scholar]
  2. Cairns J. Mutation selection and the natural history of cancer. Nature. 1975 May 15;255(5505):197–200. doi: 10.1038/255197a0. [DOI] [PubMed] [Google Scholar]
  3. Crissman J. D., Liu W. Y., Gluckman J. L., Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer. 1984 Dec 15;54(12):2995–3001. doi: 10.1002/1097-0142(19841215)54:12<2995::aid-cncr2820541230>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  4. Doyle A., Martin W. J., Funa K., Gazdar A., Carney D., Martin S. E., Linnoila I., Cuttitta F., Mulshine J., Bunn P. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med. 1985 May 1;161(5):1135–1151. doi: 10.1084/jem.161.5.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Esteban F., Concha A., Huelin C., Pérez-Ayala M., Pedrinaci S., Ruiz-Cabello F., Garrido F. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. Int J Cancer. 1989 Mar 15;43(3):436–442. doi: 10.1002/ijc.2910430316. [DOI] [PubMed] [Google Scholar]
  6. Esteban F., Ruiz-Cabello F., Concha A., Pérez-Ayala M., Sánchez-Rozas J. A., Garrido F. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis. 1990 Jul-Aug;8(4):319–328. doi: 10.1007/BF01810678. [DOI] [PubMed] [Google Scholar]
  7. Festenstein H., Garrido F. MHC antigens and malignancy. Nature. 1986 Aug 7;322(6079):502–503. doi: 10.1038/322502a0. [DOI] [PubMed] [Google Scholar]
  8. Jakobsson P. A., Eneroth C. M., Killander D., Moberger G., Mårtensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol. 1973 Feb;12(1):1–8. doi: 10.3109/02841867309131085. [DOI] [PubMed] [Google Scholar]
  9. Kirchner J. A., Carter D. Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol. 1987 May-Jun;103(5-6):503–513. [PubMed] [Google Scholar]
  10. Kirchner J. A., Cornog J. L., Jr, Holmes R. E. Transglottic cancer. Its growth and spread within the larynx. Arch Otolaryngol. 1974 Apr;99(4):247–251. doi: 10.1001/archotol.1974.00780030257003. [DOI] [PubMed] [Google Scholar]
  11. Klein G., Klein E. Evolution of tumours and the impact of molecular oncology. Nature. 1985 May 16;315(6016):190–195. doi: 10.1038/315190a0. [DOI] [PubMed] [Google Scholar]
  12. Lampson L. A., Fisher C. A., Whelan J. P. Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. J Immunol. 1983 May;130(5):2471–2478. [PubMed] [Google Scholar]
  13. Lopez Nevot M. A., Garcia E., Pareja E., Bonal F. J., Martin J., Ruiz-Cabello F., Serrano S., Garrido F. Differential expression of HLA class I and II antigens in primary and metastatic melanomas. J Immunogenet. 1986 Apr-Jun;13(2-3):219–227. doi: 10.1111/j.1744-313x.1986.tb01104.x. [DOI] [PubMed] [Google Scholar]
  14. López-Nevot M. A., Esteban F., Ferrón A., Gutiérrez J., Oliva M. R., Romero C., Huelin C., Ruiz-Cabello F., Garrido F. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer. 1989 Feb;59(2):221–226. doi: 10.1038/bjc.1989.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MCGAVRAN M. H., BAUER W. C., OGURA J. H. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. A study based on the clinical and pathological findings for 96 patients treated by primary en bloc laryngectomy and radical neck dissection. Cancer. 1961 Jan-Feb;14:55–66. doi: 10.1002/1097-0142(196101/02)14:1<55::aid-cncr2820140109>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  16. Momburg F., Möller P., Moldenhauer G., Hämmerling G. J. Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiation. J Immunogenet. 1986 Apr-Jun;13(2-3):195–199. doi: 10.1111/j.1744-313x.1986.tb01101.x. [DOI] [PubMed] [Google Scholar]
  17. Pera E., Moreno A., Galindo L. Prognostic factors in laryngeal carcinoma. A multifactorial study of 416 cases. Cancer. 1986 Aug 15;58(4):928–934. doi: 10.1002/1097-0142(19860815)58:4<928::aid-cncr2820580421>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  18. Poleksic S., Kalwaic H. J. Prognostic value of vascular invasion in squamous cell carcinoma of the head and neck. Plast Reconstr Surg. 1978 Feb;61(2):234–240. doi: 10.1097/00006534-197802000-00014. [DOI] [PubMed] [Google Scholar]
  19. Ruiz-Cabello F., Lopez Nevot M. A., Gutierrez J., Oliva M. R., Romero C., Ferron A., Esteban F., Huelin C., Piris M. A., Rivas C. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases. Clin Exp Metastasis. 1989 Mar-Apr;7(2):213–226. doi: 10.1007/BF01787025. [DOI] [PubMed] [Google Scholar]
  20. Townsend A. R., Gotch F. M., Davey J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell. 1985 Sep;42(2):457–467. doi: 10.1016/0092-8674(85)90103-5. [DOI] [PubMed] [Google Scholar]
  21. Versteeg R., Noordermeer I. A., Krüse-Wolters M., Ruiter D. J., Schrier P. I. c-myc down-regulates class I HLA expression in human melanomas. EMBO J. 1988 Apr;7(4):1023–1029. doi: 10.1002/j.1460-2075.1988.tb02909.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Zinkernagel R. M., Doherty P. C. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 1979;27:51–177. doi: 10.1016/s0065-2776(08)60262-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES